Xeris Biopharma to Present at 41st Annual J.P. Morgan Healthcare Conference

Author's Avatar
Jan 05, 2023

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Paul R. Edick, Xeris’ Chairman and CEO, will present an overview of the Company at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 pm Pacific Time. To access the presentation, please visit “Events” on the investor relations page of the Company’s website at www.xerispharma.com.